Stock Award Plans and Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2024

Stock Award Plans and Stock-Based Compensation [Abstract]

Schedule of Stock Options Granted

See below for a summary of the stock options granted under the 2011, 2017, and 2018 plans:

				Weighted		Weighted		Aggregate
				Average		Average		Intrinsic
	Number of			Exercise		Remaining		Value
	Shares			Price		Life (Years)		(in millions)
Outstanding at January 1, 2023		3,615		$	4,425.28		7.7	$	—
Granted		1,089		$	4,677.36
Exercised		-		$	—
Expired		-		$	—
Forfeitures		(58	)	$	4,901.42
Outstanding at December 31, 2023		4,646		$	4,481.30		6.7	$	—
Legacy Inpixon stock options from merger		5		$	16,917.50
Granted		55,434		$	117.50
Exercised		(371	)	$	0.25
Expired		(3	)	$	700.00
Forfeitures		(8,526	)	$	484.00
Outstanding at December 31, 2024		51,185		$	455.00		9.3	$	—
Exercisable at December 31, 2024		3,803		$	3,330.00		7.7	$	—

Schedule of Granted Options

The options expire ten years from the grant date. Options were granted as follows:

Grantee	Grant Date	Vesting Start Date	Options Granted
Chief Executive Officer of XTI Aerospace, Inc.	6/12/2024	6/12/2024		11,250
Chief Financial Officer of XTI Aerospace, Inc.	6/12/2024	6/12/2024		6,563
Chief Executive Officer of the XTI Aerospace, Inc. Real-Time Location System Division	6/12/2024	6/12/2024		3,900
Chief Strategy Officer of XTI Aerospace, Inc.	9/19/2024	8/1/2024		4,688
Chief Legal Officer of XTI Aerospace, Inc.	10/28/2024	10/28/2024		4,688
Total Granted				31,089

Schedule of Fair Values of Options

The following assumptions were used in estimating the fair values of options awarded during the year ended December 31, 2024:

	For the Year Ended December 31, 2024
Fair value of common stock	$10.75 - $118.25
Exercise price	$10.75 - $118.25
Expected term	6 years
Volatility	95.06% -103.3%
Risk-free interest rate	3.51% - 4.43%
Dividend yield	—%

The following assumptions were used in estimating the fair values of options awarded during the year ended December 31, 2023:

	For the Year Ended December 31, 2023
Fair value of common stock		$4,677.36
Exercise price		$4,677.36
Expected term		5 years
Volatility		74.10%
Risk-free interest rate		3.54%
Dividend yield		—%

Schedule of Stock-based Compensation Charges

The Company incurred the following stock-based compensation charges for the periods indicated below (in thousands):

	Year Ended December 31,
	2024			2023
Employee and consultant stock options1	$	(1,798	)	$	1,645
Professional fees1		270			—
Vesting of previously unvested warrants2		496			—
Merger-related professional fees2		5,153			—
Total	$	4,121		$	1,645

1 amount included in general and administrative expenses on the consolidated statements of operations

2 amount included in merger-related transaction costs on the consolidated statements of operations